Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Peetz Christopher sold 20,000 Mirum Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 6, 2026 · Filed Jul 8, 2026
On Jul 6, 2026, Peetz Christopher (Director, CHIEF EXECUTIVE OFFICER) sold 20,000 Mirum Pharmaceuticals, Inc. shares at an average US$122.27 for US$2.45M under a trading plan, leaving 194,309 shares. Filed Jul 8, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$122.27 average (US$121.65 to US$124.79)
- Value
- US$2.45M
- Holding after
- 194,309 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Option exercise | 20,000 | US$2.94 | 214,309 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 12,134 | US$121.65 | 202,175 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 4,181 | US$122.34 | 197,994 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 1,975 | US$123.74 | 196,019 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 1,710 | US$124.79 | 194,309 | Direct |
Source
Related
- Mirum Pharmaceuticals, Inc.
- Peetz Christopher
- Mirum Pharmaceuticals, Inc. shareholders
- Form 4 · Peetz Christopher · Oct 6, 2026
- Form 4 · Peetz Christopher · Sep 3, 2026
- Form 4 · Peetz Christopher · Aug 11, 2026
- Form 4 · Peetz Christopher · Jun 2, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Bjerkholt Eric · Sep 15, 2026
- Form 4 · Howe Jolanda · Sep 3, 2026
- Form 4 · Howe Jolanda · Aug 19, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026